Effects of aspirin on serum C-reactive protein and interleukin-6 levels in patients with type 2 diabetes without cardiovascular disease: a randomized placebo-controlled crossover trial. (Q46885155)
Jump to navigation
Jump to search
scientific article published on 22 November 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | Effects of aspirin on serum C-reactive protein and interleukin-6 levels in patients with type 2 diabetes without cardiovascular disease: a randomized placebo-controlled crossover trial. |
scientific article published on 22 November 2007 |
Statements
Effects of aspirin on serum C-reactive protein and interleukin-6 levels in patients with type 2 diabetes without cardiovascular disease: a randomized placebo-controlled crossover trial (English)
Hovens MM
Frölich M
Tamsma JT
22 November 2007
1 reference
1 reference
1 reference
1 reference